Opal Wealth Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Opal Wealth Advisors's NVS Position: Q3 2026 in Review
Opal Wealth Advisors reduced its Novartis (NVS) stake by 32% in Q3 2026, selling an estimated $214K and leaving 2,970 shares worth $423K. The position accounts for 0.09% of the portfolio, ranked #119.
Opal Wealth Advisors first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $708K in Q1 2026. 939 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Opal Wealth Advisors held 2,970 shares of Novartis worth $423K as of Q3 2026.
- Opal Wealth Advisors sold 1,413 Novartis shares in Q3 2026, an estimated $214K.
- Novartis made up 0.09% of Opal Wealth Advisors's portfolio in Q3 2026, its #119 holding.
- Opal Wealth Advisors first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
- Opal Wealth Advisors's Novartis position peaked at $708K in Q1 2026.
- 939 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Opal Wealth Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.